TY - JOUR
T1 - Smoking Cessation, Version 3.2022
AU - Shields, Peter G.
AU - Bierut, Laura
AU - Arenberg, Douglas
AU - Balis, David
AU - Cinciripini, Paul M.
AU - Davis, James
AU - Edmondson, Donna
AU - Feliciano, Joy
AU - Hitsman, Brian
AU - Hudmon, Karen S.
AU - Jaklitsch, Michael T.
AU - Leone, Frank T.
AU - Ling, Pamela
AU - McCarthy, Danielle E.
AU - Ong, Michael K.
AU - Park, Elyse R.
AU - Prochaska, Judith
AU - Sandoval, Argelia J.
AU - Sheffer, Christine E.
AU - Spencer, Sharon
AU - Studts, Jamie L.
AU - Tanvetyanon, Tawee
AU - Tindle, Hilary A.
AU - Tong, Elisa
AU - Triplette, Matthew
AU - Urbanic, James
AU - Videtic, Gregory
AU - Warner, David
AU - Whitlock, C. Will
AU - McCullough, Beth
AU - Darlow, Susan
N1 - Publisher Copyright:
© 2023 Harborside Press. All rights reserved.
PY - 2023/3
Y1 - 2023/3
N2 - Although the harmful effects of smoking after a cancer diagnosis have been clearly demonstrated, many patients continue to smoke cigarettes during treatment and beyond. The NCCN Guidelines for Smoking Cessation emphasize the importance of smoking cessation in all patients with cancer and seek to establish evidence-based recommendations tailored to the unique needs and concerns of patients with cancer. The recommendations contained herein describe interventions for cessation of all combustible tobacco products (eg, cigarettes, cigars, hookah), including smokeless tobacco products. However, recommendations are based on studies of cigarette smoking. The NCCN Smoking Cessation Panel recommends that treatment plans for all patients with cancer who smoke include the following 3 tenets that should be done concurrently: (1) evidence-based motivational strategies and behavior therapy (counseling), which can be brief; (2) evidence-based pharmacotherapy; and (3) close follow-upwith retreatment as needed.
AB - Although the harmful effects of smoking after a cancer diagnosis have been clearly demonstrated, many patients continue to smoke cigarettes during treatment and beyond. The NCCN Guidelines for Smoking Cessation emphasize the importance of smoking cessation in all patients with cancer and seek to establish evidence-based recommendations tailored to the unique needs and concerns of patients with cancer. The recommendations contained herein describe interventions for cessation of all combustible tobacco products (eg, cigarettes, cigars, hookah), including smokeless tobacco products. However, recommendations are based on studies of cigarette smoking. The NCCN Smoking Cessation Panel recommends that treatment plans for all patients with cancer who smoke include the following 3 tenets that should be done concurrently: (1) evidence-based motivational strategies and behavior therapy (counseling), which can be brief; (2) evidence-based pharmacotherapy; and (3) close follow-upwith retreatment as needed.
UR - http://www.scopus.com/inward/record.url?scp=85150006635&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2023.0013
DO - 10.6004/jnccn.2023.0013
M3 - Review article
C2 - 36898367
AN - SCOPUS:85150006635
SN - 1540-1405
VL - 21
SP - 297
EP - 322
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 3
ER -